Comparison of p53 immunoexpression with allelic loss of p53 in ulcerative colitis-associated dysplasia and carcinoma

Oncology Reports

Volumn 5, Issue 2, 1998, Pages 477-480

  Fogt, Franz ^a   Zhuang, Zengping ^b   Poremba, Christopher ^c   Dockhorn Dworniczak, Barbara ^c   Vortmeyer, Alexander ^b  

^a PENN PRESBYTERIAN MEDICAL CENTER   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

Loss of heterozygosity; p53; Ulcerative colitis

Indexed keywords

DNA; PROTEIN P53;

ADULT; AGED; ALLELE; ARTICLE; CARCINOMA; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DYSPLASIA; GENE DELETION; GENE EXPRESSION; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; POLYMERASE CHAIN REACTION; PREDICTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR SUPPRESSOR GENE; ULCERATIVE COLITIS;

EID: 0031935768     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: 10.3892/or.5.2.477     Document Type: Article

References (20)

1. Ridell RH: Implications of a diagnosis of dysplasia in ulcerative colitis. J Gastroenterol 30 (Suppl VIII): 25-29, 1995.
2. Benhattar J and Saraga E: Molecular genetics of dysplasia in ulcerative colitis. Eur J Cancer 31 A: 1171-1173, 1995.
3. Costa A, Marasca R, Valentinis B, Savarino M, Faranda A, Silvestrini R and Torelli G: p53 gene point mutations in relation to p53 nuclear protein accumulation in colorectal cancers. J Pathol 176: 45-53, 1995.
4. Poremba C, Yandell DW, Huang Q, Little JB, Mellin W, Schmid KW, Baecker W and Dockhorn-Dwomiczak B: Frequency and spectrum of p53 mutations in gastric cancer. A molecular genetic and immunohistochemical study. Virchows Arch 426: 447-455, 1995.
5. Poremba C, Yandell DW, Metze D, Kamanabrou D, Baecker W and Dockhorn-Dwomiczak B: Immunohistochemical detection of p53 in melanomas with rare p53 gene mutations is associated with mdm-2 overexpression. Oncol Res 7: 331-339, 1995.
6. Zhuang Z, Bertheau P, Emmert-Buck M, Liotta L, Gnarra J, Linehan W and Lubensky IA: A new microdissection technique for archival DNA analysis of specific cell populations in lesions less than one millimeter in size. Am J Pathol 146: 620-625, 1995.
7. Lashner BA, Kane SV and Hanauer SB: Colon cancer surveillance in chronic ulcerative colitis: Historical cohort study. Am J Gastroenterol 85: 1083-1087, 1990.
8. Goldman H: In: Gastrointestinal Mucosal Biopsy. Churchill Livingstone, pp499, 1996.
9. Shelton AA, Lehman RE, Schrock TR and Welton ML: Retrospective review of colorectal cancer in ulcerative colitis at a tertiary center. Arch Surg 131: 806-810, 1996.
10. Nishisho I, Nakamura Y, Miyoshi Y, et al. Mutations of chromosome 5q21 genes in FAP and colorectal cancer. Science 253: 665-669, 1991.
11. Vogelstein B, Fearon ER, Hamilton SR, Kern S, Preisinger AC, Leppert M, Nakamura Y, White R, Smits AMM and Bos JL: Genetic alterations during colorectal tumor development. N Engl J Med 319: 525-532, 1988.
12. Greenwald BD, Harpaz N, Yin J, Huang Y, Tong Y, Brown VL, McDaniel T, Newkirk C, Resau JH and Meltzer SJ: Loss of heterozygosity affecting the p53, Rb and mcc/apc tumor suppressor gene loci in dysplastic and cancerous ulcerative colitis. Cancer Res 52: 741-745, 1992.
13. Tarmin L, Yin J, Harpaz N, Kozam M, Noordizij J, Antonio LB, Jiang HY, Chan O, Cymes K and Meltzer SJ: Adenomatous polyposis coli gene mutations in ulcerative colitis associated dysplasias and cancers versus sporadic colon neoplasms. Cancer Res 55: 2035-2038, 1995.
14. Fogt F, Vortmeyer AO, Goldman H, Giordano TJ, Merino MJ and Zhuang Z: Comparison of genetic alterations in colonic adenoma and ulcerative colitis-associated dysplasia and carcinoma. Human Pathol (In press).
15. Brentall TA, Crispin DA, Rabinovitch PS, Haggitt RC, Rubin CE, Stevens AC and Burmer GC: Mutations in the p53 gene: an early marker of neoplastic progression in ulcerative colitis. Gastroenterology 107: 369-378, 1994.
16. Nixon JB, Burdick JS and Mirza AH: Premalignant changes in ulcerative colitis. Semin Oncol 11: 386-393, 1995.
17. Louis DN, von Deimling A, Chung RY, Rubio MP, Whaley JM, Eibl RH, Ohgaki H, Wiestler OD, Thor AD and Seizinger BR: Comparative study of p53 gene and protein alterations in human astrocytic tumors. J Neuropathol Exp Neurol 52: 31-38, 1993.
18. Lang FF, Miller DC, Koslow M and Newcomb EW: Pathways leading to glioblastoma multiform: a molecular analysis of genetic alterations in 65 astrocytic tumors. J Neurosurg 81: 427-436, 1994.
19. Hagel C, Laking G, Laas R, Scheil S, Jung R, Milde-Langosch K and Stavrou DK: Demonstration of p53 protein and TP53 gene mutations in oligodendrogliomas. Eur J Cancer 32A: 2242-2248, 1996.
20. Oliner JD, Kinzler KW, Meltzer PS, George DL and Vogelstein B: Amplification of a gene encoding a p53 associated protein in human sarcomas. Nature 358: 80-83, 1992.